Strata Critical Medical (SRTA) Depreciation and Depletion (2021 - 2026)

Strata Critical Medical has disclosed Depreciation and Depletion across 6 years of filings, most recently posting $1.6 million for Q1 2026.

• In Q1 2026, Depreciation and Depletion rose 92.89% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $5.3 million (up 87.34% YoY), while the FY2025 annual figure was $4.3 million, up 114.8% from the prior year.
• Depreciation and Depletion advanced to $1.6 million in Q1 2026, from $1.5 million in the prior quarter.
• Over the last five years, Depreciation and Depletion for SRTA reached as high as $1.6 million in Q1 2026 and fell as low as $148000.0 in Q1 2022.
• The 5-year median for Depreciation and Depletion is $663000.0 (2024), against an average of $737769.2.
• Annual changes were most pronounced in 2024 — Depreciation and Depletion surged 184.25% — and 2025, when it jumped 55.43%.
• A 5-year view of Depreciation and Depletion shows it stood at $148000.0 in 2022, then surged by 84.46% to $273000.0 in 2023, then surged by 184.25% to $776000.0 in 2024, then surged by 97.42% to $1.5 million in 2025, then grew by 2.74% to $1.6 million in 2026.
• According to Business Quant data, Depreciation and Depletion over the past three periods registered $1.6 million, $1.5 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.